Journal Home > Volume 10 , Issue 2
Food Science and Human Wellness 2021, 10(2): 131-140 https://doi.org/10.1016/j.fshw.2021.02.001
Review Article | Open Access | Issue | Published: 22 March 2021

Bioactive compounds and probiotics–a ray of hope in COVID-19 management

Show Author's Information Indu Bhushana,  Mahima Sharmaa,1,  Malvika Mehtaa,1,  Shivi Badyala,  Varun Sharmab,  Indu Sharmab,  Hemender Singha,  Srinivas Sistlac( )
School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India
Birbal Sahni Institute of Palaeosciences, Lucknow, UP, India
Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, USA

1 These authors contributed equally to this work.

Peer review under responsibility of KeAi Communications Co., Ltd

Keywords:
Probiotics, Bioactive compounds, Metabolites, COVID, Food
Cite this article:
Bhushan I, Sharma M, Mehta M, et al. Bioactive compounds and probiotics–a ray of hope in COVID-19 management. Food Science and Human Wellness, 2021, 10(2): 131-140. https://doi.org/10.1016/j.fshw.2021.02.001
Download citation
EndNote(RIS)
BibTeX

364

Views

25

Downloads

Citations

36

Crossref

32

WoS

35

Scopus

1

CSCD

Abstract Full text About this article

The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti-viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance immunity. This review highlights some of the important bioactive compounds and probiotic bacteria, suggesting them as a ray of hope in the milieu of the COVID-19 management.


menu
Abstract
Full text
Outline
About this article

Bioactive compounds and probiotics–a ray of hope in COVID-19 management

Show Author's information Indu Bhushana, Mahima Sharmaa,1, Malvika Mehtaa,1, Shivi Badyala, Varun Sharmab, Indu Sharmab, Hemender Singha, Srinivas Sistlac( )
School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India
Birbal Sahni Institute of Palaeosciences, Lucknow, UP, India
Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, USA

1 These authors contributed equally to this work.

Peer review under responsibility of KeAi Communications Co., Ltd

Abstract

The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti-viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance immunity. This review highlights some of the important bioactive compounds and probiotic bacteria, suggesting them as a ray of hope in the milieu of the COVID-19 management.

Keywords: Probiotics, Bioactive compounds, Metabolites, COVID, Food

References(113)

[1]

P.M. K ris-Etherton, K.D. Hecker, A. Bonanome, et al., Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am. J. Med. 113 (Suppl 9B) (2002) 71S-88S. https://doi.org/10.1016/S0002-9343(01)00995-0.
DOI Google Scholar
[2]

N. Siriwardhana, N.S. Kalupahana, M. Cekanova, et al., Modulation of adipose tissue inflammation by bioactive food compounds. J. Nutr. Biochem. 24 (4) (2013) 613-623. https://doi.org/10.1016/j.jnutbio.2012.12.013.
DOI Google Scholar
[3]

J.M. Carbonell-Capella, M. Buniowska, M.J. Esteve, et al., Effect of Stevia rebaudiana addition on bioaccessibility of bioactive compounds and antioxidant activity of beverages based on exotic fruits mixed with oat following simulated human digestion. Food Chem. 184 (2015) 122-130. https://doi.org/10.1016/j.foodchem.2015.03.095.
DOI Google Scholar
[4]

N.M. Hassimotto, M.I. Genovese, F.M. Lajolo, Antioxidant activity of dietary fruits, vegetables, and commercial frozen fruit pulps. J. Agric. Food Chem. 53 (8) (2005) 2928-2935. https://doi.org/10.1021/jf047894h.
DOI Google Scholar
[5]

F. Yan, D.B. Polk, Probiotics and immune health. Curr. Opin. Gastroenterol. 27 (6) (2011) 496-501. https://doi.org/10.1097/MOG.0b013e32834baa4d.
DOI Google Scholar
[6]

J. Behnsen, E. Deriu, M. Sassone-Corsi, et al., Probiotics: properties, examples, and specific applications. Cold Spring Harb Perspect Med. 3 (3) (2013) a010074. https://doi.org/10.1101/cshperspect.a010074.
DOI Google Scholar
[7]

Z.Y. Zu, M.D. Jiang, P.P. Xu, et al., Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 296 (2) (2020) 200490. https://doi/10.1148/radiol.2020200490.
DOI Google Scholar
[8]

N. Chen, M. Zhou, X. Dong, et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395 (10223) (2020) 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7.
DOI Google Scholar
[9]

P. Zhou, X.L. Yang, X.G. Wang, et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 (7798) (2020) 270-273. https://doi.org/10.1038/s41586-020-2012-7.
DOI Google Scholar
[10]

A.P. Wu, Y.S. Peng, B.Y. Huang, et al., Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 27 (3) (2020) 325-328. https://doi.org/10.1016/j.chom.2020.02.001.
DOI Google Scholar
[11]

A.R. McCutcheon, T.E. Roberts, E. Gibbons, et al., Antiviral screening of British Columbian medicinal plants. J. Ethnopharmacol. 49 (2) (1995) 101-110. https://doi.org/10.1016/0378-8741(95)90037-3.
DOI Google Scholar
[12]

A.J. Vlietinck, D.A. Vanden Berghe, Can ethnopharmacology contribute to the development of antiviral drugs? J. Ethnopharmacol. 32 (1–3) (1991) 141-153. https://doi.org/10.1016/0378-8741(91)90112-q.
DOI Google Scholar
[13]

A.S. Setlur, S.Y. Naik, S. Skariyachan, Herbal lead as ideal bioactive compounds against probable drug targets of Ebola virus in comparison with known chemical analogue: a computational drug discovery perspective. Interdiscip Sci. 9 (2) (2017) 254-277. https://doi.org/10.1007/s12539-016-0149-8.
DOI Google Scholar
[14]
D.I. Santos, J.M.A. Saraiva, A.A. Vicente, et al., Methods for determiningbioavailability and bioaccessibility of bioactive compounds and nutrients. Innovative Thermal and Non-Thermal Processing, Bioaccessibility and Bioavailability of Nutrients and Bioactive Compounds. 2019, Elsevier. p. 23-54. https://doi.org/10.1016/B978-0-12-814174-8.00002-0.
[15]

A.E. Segneanu, S.M. Velciov, S. Olariu, et al., Bioactive molecules profile from natural compounds, in amino acid—new insights and roles in plant and animal. Intech Open. (2017) 209-228. https://dx.doi.org/10.5772/interchopen.68643.
DOI Google Scholar
[16]

A.C.M. Boon, A.P. Vos, Y.M.F. Garaus, et al., In vitro effect of bioactive compounds on influenza virus specific B-and T-cell responses. Scand. J. Immunol. 55 (1) (2002) 24-32. https://doi.org/10.1046/j.1365-3083.2002.01014.x.
DOI Google Scholar
[17]

J.S. Tregoning, J. Schwarze, Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology. Clin. Microbiol. Rev. 23 (1) (2010) 74-98. https://doi.org/10.1128/CMR.00032-09.
DOI Google Scholar
[18]

R.B. Couch, J.A. Englund, Respiratory viral infections in immunocompetent and immunocompromised persons. Am. J. Med. 102 (3) (1997) 2-9. https://doi.org/10.1016/S0002-9343(97)00003-X.
DOI Google Scholar
[19]

S.Y. Li, C. Chen, H.Q. Zhang, et al., Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antiviral Res. 67 (1) (2005) 18-23. https://doi.org/10.1016/j.antiviral.2005.02.007.
DOI Google Scholar
[20]

C.C. Wen, Y.H. Kuo, J.T. Jan, et al., Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J. Med. Chem. 50 (17) (2007) 4087-4095. https://doi.org/10.1021/jm070295s.
DOI Google Scholar
[21]

G. Hoever, L. Baltina, M. Michaelis, et al., Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J. Med. Chem. 48 (4) (2005) 1256-1259. https://doi.org/10.1021/jm0493008.
DOI Google Scholar
[22]
H. Chon, Medicinal herbs and plant extracts for influenza: bioactivity, mechanism of anti-influenza effects, and modulation of immune responses, in Studies in Natural Products Chemistry. 2012, Elsevier. p. 305-323. https://doi.org/10.1016/B978-0-444-59530-0.00011-3.
[23]

C.M. Galanakis, The food systems in the era of the coronavirus (COVID-19) pandemic crisis. Foods. 9 (4) (2020) 523. https://doi.org/10.3390/foods9040523.
DOI Google Scholar
[24]
Alipio, M., Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID-19). Available at SSRN 3571484, 2020. https://dx.doi.org/10.2139/ssrn.3571484.
[25]

W.B. Grant, H. Lahore, S.L. McDonnell, et al., Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 12 (4) (2020) 988. https://doi.org/10.3390/nu12040988.
DOI Google Scholar
[26]

T.E. Tallei, S.G. Tumilaar, N.J. Niode, et al., Potential of plant bioactive compounds as SARS-CoV-2 main protease (Mpro) and spike (S) glycoprotein inhibitors: a molecular docking study. Prepr. (2020) 2020040102. https://doi.org/10.20944/preprints202004.0102.v3.
DOI Google Scholar
[27]

W. Li, M. Moore, N. Vasilieva, et al., Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (6965) (2003) 450-454. https://doi.org/10.1038/nature02145.
DOI Google Scholar
[28]

K. Kuba, Y. Imai, S. Rao, et al., A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 11 (8) (2005) 875-879. https://doi.org/10.1038/nm1267.
DOI Google Scholar
[29]

M. Gheblawi, K. Wang, A. Viveiros, et al., Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ. Res. 126 (10) (2020) 1456-1474. https://doi.org/10.1161/CIRCRESAHA.120.317015.
DOI Google Scholar
[30]

W.L. Klaus, N. Yukiko, Food bioactives, micronutrients, immune function and COVID-19. J. Food Bioactive. 10 (2020). https://doi.org/10.31665/JFB.2020.10222.
DOI Google Scholar
[31]
A.K. Mishra, S.P. Tewari, In silico screening of some naturally occurring bioactive compounds predicts potential inhibitors against SARS-COV-2 (COVID-19) protease. arXiv preprint arXiv: 2004.01634, (2020).
[32]

S. Khaerunnisa, H. Kurniawan, R. Awaluddin, et al., Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Prepr. (2020) 1-14. https://doi.org/10.20944/preprints202003.0226.v1.
DOI Google Scholar
[33]

A. Balkrishna, S. Pokhrel, J. Singh, et al., Withanone from Withania somnifera may inhibit novel Coronavirus (COVID-19) entry by disrupting interactions between viral S-protein receptor binding domain and host ACE2 receptor. Research Square. (2020). https://doi.org/10.21203/rs.3.rs-17806/v1.
DOI Google Scholar
[34]

M.S. Yu, J. Lee, J.M. Lee, et al., Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. Bioorg. Med. Chem. Lett. 22 (12) (2012) 4049-4054. https://doi.org/10.1016/j.bmcl.2012.04.081.
DOI Google Scholar
[35]

J. Talukdar, S. Dasgupta, V. Nagle, et al., COVID-19: potential of microalgae derived natural astaxanthin as adjunctive supplement in alleviating cytokine storm. Prepr. (2020) 3579738. http://dx.doi.org/10.2139/ssrn.3579738.
DOI Google Scholar
[36]

A. Perez-Lopez, J. Behnsen, S.P. Nuccio, et al., Mucosal immunity to pathogenic intestinal bacteria. Nat. Rev. Immunol. 16 (3) (2016) 135-148. https://doi.org/10.1038/nri.2015.17.
DOI Google Scholar
[37]

Y. Goto, S. Uematsu, H. Kiyono, Epithelial glycosylation in gut homeostasis and inflammation. Nat. Immunol. 17 (11) (2016) 1244-1251. https://doi.org/10.1038/ni.3587.
DOI Google Scholar
[38]

D.R. Samuelson, D.A. Welsh, J.E. Shellito, Regulation of lung immunity and host defense by the intestinal microbiota. Front. Microbiol. 6 (2015) 1085. https://doi.org/10.3389/fmicb.2015.01085.
DOI Google Scholar
[39]

T. Ichinohe, I.K. Pang, Y. Kumamoto, et al., Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U. S. A. 108 (13) (2011) 5354-5359. https://doi.org/10.1073/pnas.1019378108.
DOI Google Scholar
[40]

S. Guandalini, Probiotics for prevention and treatment of diarrhea. J. Clin. Gastroenterol. 45 (Suppl) (2011) S149-S153. https://doi.org/10.1097/MCG.0b013e3182257e98.
DOI Google Scholar
[41]

M.K. Park, V. NGO, Y.M. Kwon, et al., Lactobacillus plantarum DK119 as a probiotic confers protection against influenza virus by modulating innate immunity. PLoS One 8 (10) (2013) e75368. https://doi.org/10.1371/journal.pone.0075368.
DOI Google Scholar
[42]

L. Lehtoranta, A. Pitkäranta, R. Korpela, Probiotics in respiratory virus infections. Eur. J. Clin. Microbiol. Infect Dis. 33 (8) (2014) 1289-1302. https://doi.org/10.1007/s10096-014-2086-y.
DOI Google Scholar
[43]

C. Hill, F. Guarner, G. Reid, et al., Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 11 (8) (2014) 506-514. https://doi.org/10.1038/nrgastro.2014.66.
DOI Google Scholar
[44]

V. Taverniti, S. Guglielmetti, The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr. 6 (3) (2011) 261-274. https://doi.org/10.1007/s12263-011-0218-x.
DOI Google Scholar
[45]

E. Isolauri, P. Kirjavainen, S. Salminen, Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 50 (Suppl 3) (2002) III54-III59. https://doi.org/10.1136/gut.50.suppl_3.iii54.
DOI Google Scholar
[46]

M. Kumpu, R.A. Kekkonen, R. Korpela, et al., Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial. Benef. Microbes. 6 (5) (2015) 631-639. https://doi.org/10.3920/BM2014.0164.
DOI Google Scholar
[47]

K.N.C. Sindhu, T.V. Sowmyanarayanan, A. Paul, et al., Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 58 (8) (2014) 1107-1115. https://doi.org/10.1093/cid/ciu065.
DOI Google Scholar
[48]

M. Gleeson, N.C. Bishop, L. Struszczak, Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled, randomized trial. Eur. J. Appl. Physiol. 116 (8) (2016) 1555-1563. https://doi.org/10.1007/s00421-016-3415-x.
DOI Google Scholar
[49]

K. Van Puyenbroeck, N. Hens, S. Coenen, et al., Efficacy of daily intake of Lactobacillus casei Shirota on respiratory symptoms and influenza vaccination immune response: a randomized, double-blind, placebo-controlled trial in healthy elderly nursing home residents. Am. J. Clin. Nutr. 95 (5) (2012) 1165-1171. https://doi.org/10.3945/ajcn.111.026831.
DOI Google Scholar
[50]

L. Jespersen, I. Taronw, D. Eskesen, et al., Effect of Lactobacillus paracasei subsp. paracasei, L. casei 431 on immune response to influenza vaccination and upper respiratory tract infections in healthy adult volunteers: a randomized, double-blind, placebo-controlled, parallel-group study. Am. J. Clin. Nutr. 101 (6) (2015) 1188-1196. https://doi.org/10.3945/ajcn.114.103531.
DOI Google Scholar
[51]

G. Rizzardini, D. Eskesen, P.C. Calder, et al., Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12(R) and Lactobacillus paracasei ssp. paracasei, L. casei 431(R) in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br. J. Nut. 107 (6) (2012) 876-884. https://doi.org/10.1017/S000711451100420X.
DOI Google Scholar
[52]

C.A. Pedone, C.C. Arnaud, E.R. Postaire, et al., Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int. J. Clin. Pract. 54 (9) (2000) 568-571.
Google Scholar
[53]

T. Nagai, S. Makino, S. Ikegami, et al., Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 and its exopolysaccharides against influenza virus infection in mice. Int Immunopharmacol. 11 (12) (2011) 2246-2250. https://doi.org/10.1016/j.intimp.2011.09.012.
DOI Google Scholar
[54]

S. Makino, A. Sato, A. Goto, et al., Enhanced natural killer cell activation by exopolysaccharides derived from yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1. J. Dairy Sci. 99 (2) (2016) 915-923. https://doi.org/10.3168/jds.2015-10376.
DOI Google Scholar
[55]

Y. Hirose, S. Murosaki, Y. Yamamoto, et al., Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults. J. Nutr. 136 (12) (2006) 3069-3073. https://doi.org/10.1093/jn/136.12.3069.
DOI Google Scholar
[56]

Y. Arimori, R. Nakamura, Y. Hirose, et al., Daily intake of heat-killed Lactobacillus plantarum L-137 enhances type I interferon production in healthy humans and pigs. Immunopharmacol Immunotoxicol. 34 (6) (2012) 937-943. https://doi.org/10.3109/08923973.2012.672425.
DOI Google Scholar
[57]

Y. Hirose, Y. Yamamoto, Y. Yoshikai, et al., Oral intake of heat-killed Lactobacillus plantarum L-137 decreases the incidence of upper respiratory tract infection in healthy subjects with high levels of psychological stress. J. Nutr. Sci. 6;2 (2013) e39. https://doi.org/10.1017/jns.2013.35.
DOI Google Scholar
[58]

K.M. Oo, A.A. Lwin, Y.Y. Kyaw, et al., Safety and long-term effect of the probiotic FK-23 in patients with hepatitis C virus infection. Biosci. Microbiota. Food Health. 35 (3) (2016) 123-128. https://doi.org/10.12938/bmfh.2015-024.
DOI Google Scholar
[59]

G. Grandy, M. Medina, R. Soria, et al., Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis. 25 (2010) 253. https://doi.org/10.1186/1471-2334-10-253.
DOI Google Scholar
[60]

T. Sugimura, K. Jounai, K. Ohshio, et al., Immunomodulatory effect of Lactococcus lactis JCM5805 on human plasmacytoid dendritic cells. Clin. Immunol. 149 (3) (2013) 509-518. https://doi.org/10.1016/j.clim.2013.10.007.
DOI Google Scholar
[61]

T. Sugimura, H. Takahashi, K. Jounai, et al., Effects of oral intake of plasmacytoid dendritic cells-stimulative lactic acid bacterial strain on pathogenesis of influenza-like illness and immunological response to influenza virus. Br. J. Nutr. 114 (5) (2015) 727-733. https://doi.org/10.1017/S0007114515002408.
DOI Google Scholar
[62]

T. Kawahara, T. Takahashi, K. Oishi, et al., Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model. Microbiol Immunol. 59 (1) (2015) 1-12. https://doi.org/10.1111/1348-0421.12210.
DOI Google Scholar
[63]

N. Iwabuchi, J.Z. Xiao, T. Yaeshima, et al., Oral administration of Bifidobacterium longum ameliorates influenza virus infection in mice. Biol. Pharm. Bull. 34 (8) (2011) 1352-1355. https://doi.org/10.1248/bpb.34.1352.
DOI Google Scholar
[64]

G. Rizzardini, D. Eskesen, P.C. Calder, et al., Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br. J. Nutr. 107 (6) (2012) 876-884. https://doi.org/10.1017/S000711451100420X.
DOI Google Scholar
[65]

J.Y. Kang, D.Y. Lee, N.J. Ha, et al., Antiviral effects of Lactobacillus ruminis SPM0211 and Bifidobacterium longum SPM1205 and SPM1206 on rotavirus-infected Caco-2 cells and a neonatal mouse model. J. Microbiol. 53 (11) (2015) 796-803. https://doi.org/10.1007/s12275-015-5302-2.
DOI Google Scholar
[66]

M. de Vrese, P. Winkler, P. Rautenberg, et al., Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin. Nutr. 24 (4) (2005) 481-491. https://doi.org/10.1016/j.clnu.2005.02.006.
DOI Google Scholar
[67]

J.M. Saavedra, N.A. Bauman, I. Oung, et al., Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet. 344 (8929) (1994) 1046-1049. https://doi.org/10.1016/s0140-6736(94)91708-6.
DOI Google Scholar
[68]

G. Gonzalez-Ochoa, L.K. Flores-Mendoza, R. Icedo-Garcia, et al., Modulation of rotavirus severe gastroenteritis by the combination of probiotics and prebiotics. Arch. Microbiol. 199 (7) (2017) 953-961. https://doi.org/10.1007/s00203-017-1400-3.
DOI Google Scholar
[69]

R. Enaud, R. Prevel, E. Ciarlo, et al., The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks. Front. Cell Infect Microbiol. 10 (2020) 9. https://doi.org/10.3389/fcimb.2020.00009.
DOI Google Scholar
[70]

V. Kumar, K. Baruah, D.V. Nguyen, et al., Phloroglucinol-mediated Hsp70 production in crustaceans: protection against Vibrio parahaemolyticus in Artemia franciscana and Macrobrachium rosenbergii. Front. Immunol. 9 (2018) 1091. https://doi.org/10.3389/fimmu.2018.01091.
DOI Google Scholar
[71]

V. Sencio, A. Barthelemy, L.P. Tavares, et al., Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Rep. 30 (9) (2020) 2934-2947. https://doi.org/10.1016/j.celrep.2020.02.013.
DOI Google Scholar
[72]

Q.Y. Gao, Y.X. Chen, J.Y. Fang, 2019 novel coronavirus infection and gastrointestinal tract. J. Dig. Dis. 21 (3) (2020) 125-126. https://doi.org/10.1111/1751-2980.12851.
DOI Google Scholar
[73]

K. Xu, H.L. Cai, Y.H. Shen, et al., Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Journal of Zhejiang University (medical science) 49 (1) (2020) 147-157.
Google Scholar
[74]

F. Di Pierro, A possible probiotic (S. salivarius K12) approach to improve oral and lung microbiotas and raise defenses against SARS-CoV-2. Minerva. Med. 111 (3) (2020) 281-283. https://doi.org/10.23736/s0026-4806.20.06570-2.
DOI Google Scholar
[75]

H. Getahun, C. Gunneberg, R. Granich, et al., HIV infection—associated tuberculosis: the epidemiology and the response. Clin. Infect Dis. 50 (Supplement_3) (2010) S201-S207. https://doi.org/10.1086/651492.
DOI Google Scholar
[76]

W.D. Chai, M. Burwinkel, Z.Y. Wang, et al., Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus. Arch. Virol. 158 (4) (2013) 799-807. https://doi.org/10.1007/s00705-012-1543-0.
DOI Google Scholar
[77]

Y.S. Liu, Q. Liu, Y.L. Jiang, et al., Surface-displayed porcine IFN-λ3 in Lactobacillus plantarum inhibits porcine enteric coronavirus infection of porcine intestinal epithelial cells. J. Microbiol. Biotechnol. 30 (4) (2020) 515-525. https://doi.org/10.4014/jmb.1909.09041.
DOI Google Scholar
[78]

R.V.J. Kumar, B.J. Seo, M.R. Mun, et al., Putative probiotic Lactobacillus spp. from porcine gastrointestinal tract inhibit transmissible gastroenteritis coronavirus and enteric bacterial pathogens. Trop Anim. Health Prod. 42 (8) (2010) 1855-1860. https://doi.org/10.1007/s11250-010-9648-5.
DOI Google Scholar
[79]

K. Wang, L. Ran, T. Yan, et al., Anti-TGEV miller strain infection effect of Lactobacillus plantarum supernatant based on the JAK-STAT1 signaling pathway. Front Microbiol. 10 (2019) 2540. https://doi.org/10.3389/fmicb.2019.02540.
DOI Google Scholar
[80]

A. Shoaib, L. Xin, Y. Xin, Oral administration of Lactobacillus acidophilus alleviates exacerbations in Pseudomonas aeruginosa and Staphylococcus aureus pulmonary infections. Pak. J. Pharm. Sci. 32 (2019) 1621-1630.
Google Scholar
[81]

A. Ceribelli, F. Motta, M. De Santis, et al., Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy. J. Autoimmun. 109 (2020) 102442. https://doi.org/10.1016/j.jaut.2020.102442.
DOI Google Scholar
[82]

M. Mahooti, E. Abdolalipour, A. Salehzadeh, et al., Immunomodulatory and prophylactic effects of Bifidobacterium bifidum probiotic strain on influenza infection in mice. World J. Microbiol. Biotechnol. 35 (6) (2019) 91. https://doi.org/10.1007/s11274-019-2667-0.
DOI Google Scholar
[83]

K. Eguchi, N. Fujitani, H. Nakagawa, et al., Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055. Sci. Rep. 9 (1) (2019) 1-11. https://doi.org/10.1038/s41598-019-39602-7.
DOI Google Scholar
[84]

F.F. Pu, Y. Guo, M. Lin, et al., Yogurt supplemented with probiotics can protect the healthy elderly from respiratory infections: a randomized controlled open-label trial. Clin. Interv. Aging. 12 (2017) 1223-1231. https://doi.org/10.2147/cia.s141518.
DOI Google Scholar
[85]

F. D'Amico, D.C. Baumgart, S. Danses, et al., Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management. Clin. Gastroenterol. Hepatol. 18 (8) (2020) 1663-1672. https://doi.org/10.1016/j.cgh.2020.04.001.
DOI Google Scholar
[86]

A.T. Xiao, Y.X. Tong, C. Gao, et al., Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study. J. Clin. Virol. 127 (2020) 104346. https://doi.org/10.1016/j.jcv.2020.104346.
DOI Google Scholar
[87]

S. Raghuwanshi, S. Misra, P. Bisen, Indian perspective for probiotics: a review. Indian J. Dairy Sci. 68 (3) (2015) 195-205.
Google Scholar
[88]

D. Dhar, A. Mohanty, Gut microbiota and Covid-19-possible link and implications. Virus Res. (2020) 198018. https://doi.org/10.1016/j.virusres.2020.198018.
DOI Google Scholar
[89]

R. Jayawardena, P. Sooriyaarachchi, M. Chourdakis, et al., Enhancing immunity in viral infections, with special emphasis on COVID-19: a review. Diabetes Metab. Syndr. 14 (4) (2020) 367-382. https://doi.org/10.1016/j.dsx.2020.04.015.
DOI Google Scholar
[90]

J.W. Mak, F.K. Chan, S.C. Ng, Probiotics and COVID-19: one size does not fit all, Lancet Gastroenterol. Hepatol. 5 (7) (2020) 644-645. https://doi.org/10.1016/s2468-1253(20)30122-9.
DOI Google Scholar
[91]

M. Franz, H. Rodriguez, C. Lopes, et al., GeneMANIA update 2018. Nucleic Acids Res. 46 (W1) (2018) W60-W64. https://doi.org/10.1093/nar/gky311.
DOI Google Scholar
[92]

M. Hoffmann, H. Kleine-Weber, S. Schroeder, et al., SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 181(2) (2020) 271-280 e8. https://doi.org/10.1016/j.cell.2020.02.052.
DOI Google Scholar
[93]

A.C. Walls, Y.J. Park, M.A. Tortorici, et al., Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 181 (2) (2020) 281-292 e6. https://doi.org/10.1016/j.cell.2020.02.058.
DOI Google Scholar
[94]

J.W. Arnold, J.B. Simpson, J. Roach, et al., Prebiotics for lactose intolerance: variability in galacto-oligosaccharide utilization by intestinal Lactobacillus rhamnosus. Nutrients. 10 (10) (2018) 1517. https://doi.org/10.3390/nu10101517.
DOI Google Scholar
[95]

I. Jarvela, S. Torniainen, K.L. Kolho, Molecular genetics of human lactase deficiencies. Ann. Med. 41 (8) (2009) 568-575. https://doi.org/10.1080/07853890903121033.
DOI Google Scholar
[96]

X. Zou, K. Chen, J.W. Zou, et al., Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front. Med. 14 (2) (2020) 185-192. https://doi.org/10.1007/s11684-020-0754-0.
DOI Google Scholar
[97]

H. Xu, L. Zhong, J.X. Deng, et al., High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 12 (1) (2020) 8. https://doi.org/10.1038/s41368-020-0074-x.
DOI Google Scholar
[98]

H. Zhang, Z.J. Kang, H.Y. Gong, et al., Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut. 69 (6) (2020) 1010-1018. http://dx.doi.org/10.1136/gutjnl-2020-320953.
DOI Google Scholar
[99]

Y. He, Y. Tang, M. Peng, et al., Influence of Debaryomyces hansenii on bacterial lactase gene diversity in intestinal mucosa of mice with antibiotic-associated diarrhea. PLoS One. 14 (12) (2019) e0225802. https://doi.org/10.1371/journal.pone.0225802.
DOI Google Scholar
[100]

P. Gutierrez-Castrellon, G. Lopez-Velazquez, L. Diaz-Garcia, et al., Diarrhea in preschool children and Lactobacillus reuteri: a randomized controlled trial. Pediatrics. 133 (4) (2014) e904-e909. https://doi.org/10.1542/peds.2013-0652.
DOI Google Scholar
[101]

P. Tubelius, V. Stan, A. Zachrisson, Increasing work-place healthiness with the probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled study. Environ. Health. 4 (2005) 25. https://doi.org/10.1186/1476-069x-4-25.
DOI Google Scholar
[102]

P. Pimentel-Nunes, J.B. Soares, R. Roncon-Albuquerque, et al., Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin. Ther. Targets. 14 (4) (2010) 347-368. https://doi.org/10.1517/14728221003642027.
DOI Google Scholar
[103]

S. Liu, P.W. Hu, X.X. Du, et al., Lactobacillus rhamnosus GG supplementation for preventing respiratory infections in children: a meta-analysis of randomized, placebo-controlled trials. Indian Pediatr. 50 (4) (2013) 377-381. https://doi.org/10.1007/s13312-013-0123-z.
DOI Google Scholar
[104]

Y. Yamamoto, K. Fujino, J. Saruta, et al., Effects of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 on the IgA flow rate of saliva in elderly persons residing in a nursing home: a before-after non-randomised intervention study. Gerodontol. 34 (4) (2017) 479-485. https://doi.org/10.1111/ger.12296.
DOI Google Scholar
[105]

I.L. Ahren, A. Berggren, C. Teixeira, et al., Evaluation of the efficacy of Lactobacillus plantarum HEAL9 and Lactobacillus paracasei 8700:2 on aspects of common cold infections in children attending day care: a randomised, double-blind, placebo-controlled clinical study. Eur. J. Nutr. 59 (1) (2020) 409-417. https://doi.org/10.1007/s00394-019-02137-8.
DOI Google Scholar
[106]

S. Arai, N. Iwabuchi, S. Takahashi, et al., Orally administered heat-killed Lactobacillus paracasei MCC1849 enhances antigen-specific IgA secretion and induces follicular helper T cells in mice. PLoS One. 13 (6) (2018) e0199018. https://doi.org/10.1371/journal.pone.0199018.
DOI Google Scholar
[107]

E. Guillemard, F. Tondu, F. Lacoin, et al., Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br. J. Nutr. 103 (1) (2010) 58-68. https://doi.org/10.1017/s0007114509991395.
DOI Google Scholar
[108]

Y. Hirose, Y. Yamanoto, Y. Yoshikai, et al., Oral intake of heat-killed Lactobacillus plantarum L-137 decreases the incidence of upper respiratory tract infection in healthy subjects with high levels of psychological stress. J. Nutr. Sci. 2 (2013) e39. https://doi.org/10.1017/jns.2013.35.
DOI Google Scholar
[109]

K. Fukada, D. Fujikura, Y. Nakayama, et al., Enterococcus faecalis FK-23 affects alveolar-capillary permeability to attenuate leukocyte influx in lung after influenza virus infection. Springerplus. 2 (1) (2013) 269. https://doi.org/10.1186/2193-1801-2-269.
DOI Google Scholar
[110]

M. Karen, O. Yuksel, N. Akyürek, et al., Probiotic agent Saccharomyces boulardii reduces the incidence of lung injury in acute necrotizing pancreatitis induced rats. J. Surg. Res. 160 (1) (2010) 139-144. https://doi.org/10.1016/j.jss.2009.02.008.
DOI Google Scholar
[111]

H. Meng, Y. Lee, Z. Ba, et al., Consumption of Bifidobacterium animalis subsp. lactis BB-12 impacts upper respiratory tract infection and the function of NK and T cells in healthy adults. Mol. Nutr. Food Res. 60 (5) (2016) 1161-1171. https://doi.org/10.1002/mnfr.201500665.
DOI Google Scholar
[112]

M. Jungersen, A. Wind, E. Johansen, et al., The science behind the probiotic strain Bifidobacterium animalis subsp. lactis BB-12(®). Microorganisms. 2 (2) (2014) 92-110. https://doi.org/10.3390/microorganisms2020092.
DOI Google Scholar
[113]

K. Jounai, T. Sugimura, K. Ohshio, et al., Oral administration of Lactococcus lactis subsp. lactis JCM5805 enhances lung immune response resulting in protection from murine parainfluenza virus infection. PLoS One. 10 (3) (2015) e0119055. https://doi.org/10.1371/journal.pone.0119055.
DOI Google Scholar
Publication history
Copyright
Rights and permissions

Publication history

Received: 15 January 2020
Revised: 10 August 2020
Accepted: 10 August 2020
Published: 22 March 2021
Issue date: March 2021

Copyright

© 2021 Beijing Academy of Food Sciences.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return